General Pharmaceuticals Limited-International Marketing

In the ever-evolving landscape of oncology, we #General_Pharmaceuticals_Ltd introducing #Olarigen (Olaparib, 50mg Capsule, 150 mg Tablet) stands out as a of hope for patients battling various forms of cancer. This innovative medication is making significant strides in improving outcomes and quality of life for those affected by this challenging disease. #Olaparib is a potent inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, including PARP1, PARP2, and PARP3. These enzymes play a crucial role in DNA repair, and by inhibiting them, helps to prevent cancer cells from repairing themselves, leading to their death. Olarigen: - Effective as monotherapy for patients with #BRCA_mutated advanced ovarian cancer who have undergone multiple lines of chemotherapy. - Used in treating HER2-negative metastatic #breast_cancer with BRCA mutations. -Specifically targets #cancer_cells with certain genetic markers, minimizing damage to healthy cells. -Convenient capsule form allows for easier administration and better patient compliance. For more information, Visit: www.generalpharma.com Email: gmd@generalpharma.com #Olarigen #Cancer_Care #Olaparib #Oncology #IMD #Export #Cancer_Healthcare #GPL

Empowering Heart Health Worldwide with 𝐀𝐫𝐧𝐢𝐠𝐞𝐧. 🌍 We are excited to share that Arnigen 200 (Sacubitril+Valsartan) is making a profound impact in the field of cardiology, especially for those battling heart failure. This breakthrough combination therapy not only helps patients manage their condition but enhances their quality of life by reducing the risk of hospitalization and improving heart function. 𝐇𝐨𝐰 𝐀𝐫𝐧𝐢𝐠𝐞𝐧 𝐖𝐨𝐫𝐤𝐬: Arnigen combines two powerful agents: 𝐒𝐚𝐜𝐮𝐛𝐢𝐭𝐫𝐢𝐥: Inhibits neprilysin to increase levels of beneficial peptides that help reduce blood pressure and cardiac workload. 𝐕𝐚𝐥𝐬𝐚𝐫𝐭𝐚𝐧: An angiotensin receptor blocker (ARB), which complements this effect by further reducing strain on the heart. Together, they address the underlying causes of heart failure, offering a safer and more effective alternative for millions of people worldwide. 🌐 𝐀 𝐌𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 𝐢𝐧 𝐇𝐞𝐚𝐫𝐭 𝐅𝐚𝐢𝐥𝐮𝐫𝐞 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭: Heart failure is a progressive disease, and managing it effectively means giving patients more precious time and energy to enjoy their lives. As part of a broader effort to transform heart health, Arnigen represents a commitment to innovation and improving patient outcomes. 💙 𝐅𝐨𝐫 𝐨𝐫𝐝𝐞𝐫 𝐨𝐫 𝐟𝐮𝐫𝐭𝐡𝐞𝐫 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧: Email: gmd@generalpharma.com Visit our portfolio: www.generalpharma.com #HeartHealth #Cardiology #Arnigen #HeartFailure #Pharma #B2B #IMD #GPL #Bangladesh

Do you know that Osteoporosis affects approximately 6.3% of men and 21.2% of women over the age of 50? There are more than 8.9 million osteoporotic fractures annually, which means an osteoporotic fracture occurs every 3 seconds!! 𝐎𝐬𝐢𝐟𝐲, made from Ossein Hydroxyapatite, a unique formulation scientifically designed to increase bone mineral density and support stronger, healthier bones. 𝐖𝐡𝐲 𝐂𝐡𝐨𝐨𝐬𝐞 𝐎𝐬𝐢𝐟𝐲? ✅ Clinically Proven: Ossein Hydroxyapatite helps stimulate bone growth and naturally enhances bone structure. ✅ Enhanced Bone Strength: Aids in the regeneration of bone tissues, making bones more resilient against fractures. ✅ Natural Composition: Derived from organic sources, mimicking the composition of natural bone tissue. 💪 𝐄𝐦𝐩𝐨𝐰𝐞𝐫 𝐘𝐨𝐮𝐫 𝐁𝐨𝐧𝐞𝐬 𝐭𝐨 𝐓𝐡𝐫𝐢𝐯𝐞! Don't let osteoporosis hold you back. Choose Osify and take a step toward a stronger, healthier life. Because when it comes to your bones, strength matters! 𝐅𝐨𝐫 𝐨𝐫𝐝𝐞𝐫 𝐨𝐫 𝐟𝐮𝐫𝐭𝐡𝐞𝐫 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧: Email: gmd@generalpharma.com Website: www.generalpharma.com #BoneHealth #Osteoporosis #Osify #BoneDensity #OsseinHydroxyapatite #Healthcare #HealthyBones #StrongerTogether #IMD #GPL #Bangladesh

General Pharmaceuticals Ltd. is introducing 𝐁𝐮𝐝𝐞𝐟𝐚𝐧 𝐗𝐑: A New Hope for Major Depressive Disorder (MDD) Treatment. 🌟 Depression continues to affect millions of people worldwide, and there’s a growing need for innovative treatments that provide rapid relief and sustained remission. That’s where Budefan comes in. Combining Dextromethorphan and Bupropion HCl, Budefan acts as a triple reuptake inhibitor, targeting serotonin, norepinephrine, and dopamine to enhance mood regulation. But it doesn’t stop there. Budefan also works on glutamate pathways, offering a unique mechanism of action for rapid antidepressant effects and a better chance at sustained improvement. 🧠 Why Budefan? ✅ 𝐓𝐫𝐢𝐩𝐥𝐞 𝐑𝐞𝐮𝐩𝐭𝐚𝐤𝐞 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧: Comprehensive neurotransmitter support for balanced mood. ✅ 𝐆𝐥𝐮𝐭𝐚𝐦𝐚𝐭𝐞 𝐌𝐨𝐝𝐮𝐥𝐚𝐭𝐢𝐨𝐧: Targets glutamate pathways for quicker antidepressant action. ✅ 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐞𝐝 𝐑𝐞𝐦𝐢𝐬𝐬𝐢𝐨𝐧: Provides long-term relief, not just temporary alleviation. Let’s bring hope to those who need it most. 💊 Together, we can change the story of depression treatment. 𝐅𝐨𝐫 𝐨𝐫𝐝𝐞𝐫 𝐨𝐫 𝐟𝐮𝐫𝐭𝐡𝐞𝐫 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧:  Email: gmd@generalpharma.com Visit our portfolio: www.generalpharma.com #MentalHealthMatters #DepressionTreatment #Budefan #TripleReuptakeInhibitor #RapidRelief #Glutamate #Antidepressant #MDD #Antideprassant #IMD #GPL #Bangladesh

Empower Lives with Deflamax: A Breakthrough in Duchenne Muscular Dystrophy Treatment! We #General_Pharmaceuticals_Ltd introducing our new generic drug #Deflamax (Deflazacort 6mg and 24 mg Tablets) for managing muscle inflammatory conditions like Duchenne Muscular Dystrophy. It is one of the safe steroids that can ensure the safety from other side-effects. What is #Deflazacort? Deflazacort is a corticosteroid medication specifically designed to treat Duchenne muscular dystrophy in both adults and children aged 2 years and older. This condition leads to progressive muscle weakness, but Deflazacort can help improve muscle strength and slow the progression of disability. #Reduces_Inflammation: Helps manage the symptoms of DMD by reducing inflammation. #Improves_Muscle_Strength: Enhances muscle function and slows down muscle degeneration. #FDA_Approved: Recognized and approved by the FDA for its efficacy and safety. For more Information: www.generalpharma.com For any Queries or Information: emon.imd@generalpharma.com What'sApp Contact: +8801825449339 Want to learn more about Deflazacort and its benefits? Connect with us and discover how this medication can transform lives. #Deflamax #Deflazacort #GPL_IMD #Export

Fight Dermatophytes with Axita! Are you in search of an effective solution to combat stubborn fungal infections for dermatological issues? Here we #General_Pharmaceuticals_Ltd introducing our new generic drug #Axita (Itraconazole; 100 and 200 Capsule and Tablet). What is Itraconazole? #Itraconazole is a potent antifungal medication used to treat a variety of fungal infections, including those affecting the dermis, mouth, throat, toenails, and fingernails. It belongs to the azole antifungals class, which works by stopping the growth of fungi. Why Choose Itraconazole Capsules? #Broad_Spectrum_Efficacy: Effective against a wide range of fungal infections. #Convenient_Formulation: Easy-to-swallow capsules for patient convenience. #Clinically_Proven: Trusted by healthcare professionals for its safety and effectiveness. For more Information: www.generalpharma.com For any Queries or Information: emon.imd@generalpharma.com What'sApp Contact: +8801825449339 Join the Fight Against Fungal Infections Let’s spread awareness about the benefits of Itraconazole capsules and support those affected by fungal infections. Together, we can make a significant impact on patient health and well-being. #Axita #GPL_IMD #Itraconazole #Antifungal #Healthcare #PatientCare #Innovation #MedicalSolutions

Empower Lives with Deflamax: A Breakthrough in Duchenne Muscular Dystrophy Treatment! We #General_Pharmaceuticals_Ltd introducing our new generic drug #Deflamax (Deflazacort 6mg and 24 mg Tablets) for managing muscle inflammatory conditions like Duchenne Muscular Dystrophy. It is one of the safe steroids that can ensure the safety from other side-effects. What is #Deflazacort? Deflazacort is a corticosteroid medication specifically designed to treat Duchenne muscular dystrophy in both adults and children aged 2 years and older. This condition leads to progressive muscle weakness, but Deflazacort can help improve muscle strength and slow the progression of disability. #Reduces_Inflammation: Helps manage the symptoms of DMD by reducing inflammation. #Improves_Muscle_Strength: Enhances muscle function and slows down muscle degeneration. #FDA_Approved: Recognized and approved by the FDA for its efficacy and safety. For more Information: www.generalpharma.com For any Queries or Information: emon.imd@generalpharma.com What'sApp Contact: +8801825449339 Want to learn more about Deflazacort and its benefits? Connect with us and discover how this medication can transform lives. #Deflamax #Deflazacort #GPL_IMD #Export

Enhance Bone Health and Regeneration with Osify!! Are you ready to revolutionize your health and wellness products? Discover the incredible benefits of #Osify (Ossein Hydroxyapatite). We #General_Pharmaceuticals_Ltd proudly introducing first time in #Bangladesh a revolutionary medication along with the supplement Named: Osify that is ossein hydroxyapatite 600 mg and 800 mg Tablet. What is #Ossein_Hydroxyapatite? It is a naturally occurring mineral form of calcium apatite, derived from bone. It’s renowned for its exceptional biocompatibility and bioactivity, making it a top choice in various medical condition. Why Choose Ossein Hydroxyapatite? #Superior_Biocompatibility: Perfect for medical and dental applications. #Enhanced_Bioactivity: Promotes bone regeneration and healing. #Versatile_Applications: Ideal for use in supplements, cosmetics, and more. Our Ossein Hydroxyapatite is sustainably sourced and processed, ensuring minimal environmental impact while delivering maximum benefits. For more information: www.generalpharma.com For any Queries and Interest: emon.imd@generalpharma.com What'sApp Contact: +8801825449339 🔗 Connect with Us! Ready to learn more? #Osify #GPL_IMD #OsseinHydroxyapatite #Innovation #Sustainability #Healthcare #Beauty #Nutrition

Emfogen M: A Strategic Solution for Diabetes Management in Your Portfolio! We are pleased to introduce Emfogen M, a combination therapy featuring Empagliflozin + Metformin Hydrochloride, designed to meet the growing demand for effective Type 2 Diabetes management. With the convenience of three strength options, Emfogen M comes in three versatile strengths to suit diverse treatment needs: ✅ 5mg/1000mg ✅ 12.5mg/500mg ✅ 12.5mg/1000mg Adding Emfogen M to your product lineup not only enhances treatment options but also strengthens your market position in the fast-growing diabetes care segment. The combination targets multiple facets of diabetes management, delivering robust glycemic control along with added cardiovascular and renal benefits. 🌍 Partner with us to bring this innovative solution to healthcare providers and help patients achieve better health outcomes. Together, we can lead the way in diabetes care! 🤝 For order or further information: Email: gmd@generalpharma.com Visit our portfolio: www.generalpharma.com #EmfogenM #DiabetesManagement #Empagliflozin #Metformin #Type2Diabetes #B2B #Pharma #ChronicDiseaseManagement #IMD #GPL #Bangladesh

Breakthrough Therapy for Breast & Ovarian Cancer: Olarigen 50 mg Capsule & Olarigen 150 mg Tablets 🎗️ We are proud to present Olarigen, a leading-edge treatment specifically designed for patients with advanced breast and ovarian cancer, especially those with BRCA gene mutations. ✅ 𝐈𝐧𝐝𝐢𝐜𝐚𝐭𝐞𝐝 𝐟𝐨𝐫: Advanced ovarian, breast, pancreatic, and prostate cancers, especially in patients with BRCA mutations. 💡 𝐖𝐡𝐲 𝐂𝐡𝐨𝐨𝐬𝐞 𝐎𝐥𝐚𝐩𝐚𝐫𝐢𝐛? 𝐓𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐓𝐡𝐞𝐫𝐚𝐩𝐲: Inhibits PARP enzymes to prevent cancer cell repair, enhancing the effectiveness of treatment. 𝐅𝐨𝐫 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐒𝐭𝐚𝐠𝐞𝐬: Proven efficacy in patients with metastatic breast and recurrent ovarian cancers. 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞: Available in 50 mg and 150 mg strengths, providing flexible dosing options to meet individual patient needs. 💼 𝐏𝐚𝐫𝐭𝐧𝐞𝐫 𝐰𝐢𝐭𝐡 𝐔𝐬 Connect with us today to learn more about how Olarigen can be integrated into your oncology portfolio. For Order: Email: gmd@generalpharma.com Visit our portfolio: www.generalpharma.com #Oncology #BreastCancer #OvarianCancer #Olarigen50 #Olarigen150 #Olaparib #GPL #B2BPharma #IMD #Bangladesh